Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao Yao Tablet is a traditional herbal medicinal product (tHMP) based on the classic "Xiao Yao San" formula from Traditional Chinese Medicine (TCM). It was developed by the Tasly Group with regulatory support from SU BioMedicine and achieved a landmark registration in the Netherlands in 2021, making it one of the first TCM compound preparations to be authorized under the EU's simplified registration procedure for tHMPs. The product is indicated for the relief of mental stress and exhaustion symptoms, including nervous tension, irritability, and anxiety. The formula is a complex mixture of eight botanical ingredients, traditionally used to "soothe the liver and strengthen the spleen," which corresponds to regulating the stress response and digestive function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiao Yao Tablet.